PDCD1 and cancer: The discovery of immune checkpoints is a revolutionary breakthrough, and they have been applied in cancer treatment strategies, with the most representative being the interaction between programmed cell death protein 1 (PD-1) and programmed death ligand (PD-L1) [13].